SERION Immunologics Measles Virus Antigen - Premium was successfully applied in in-vitro stimulation assays to assess anti-tumor immunity induced by virotherapy.
Current News from our Company
A new microarray for the determination of a patient's vaccination status was developed by the InfectoGnostics Research Campus Jena.
Effecient removal of IgG antbodies for reliable IgM detection.
We are very pleased to inform you that the portfolio of SERION antigens is expanding further by the addition of a new recombinant VZV antigen.
Check out our magnetic beads specifically designed for quick and easy CLIA assay development.
New recombinant SARS-CoV-2 antigens complement the growing SERION Immunologics raw material portfolio for IVD assay development.